93 related articles for article (PubMed ID: 24389269)
21. Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats.
Oturai PS; Christensen M; Rolin B; Pedersen KE; Mortensen SB; Boel E
Metabolism; 2000 Aug; 49(8):996-1000. PubMed ID: 10954016
[TBL] [Abstract][Full Text] [Related]
22. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.
Reber F; Geffarth R; Kasper M; Reichenbach A; Schleicher ED; Siegner A; Funk RH
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):213-25. PubMed ID: 12644946
[TBL] [Abstract][Full Text] [Related]
23. The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.
Cooper ME; Thallas V; Forbes J; Scalbert E; Sastra S; Darby I; Soulis T
Diabetologia; 2000 May; 43(5):660-4. PubMed ID: 10855541
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5.
Lee JJ; Wang PW; Yang IH; Wu CL; Chuang JH
Int J Biochem Cell Biol; 2015 Jul; 64():1-10. PubMed ID: 25783987
[TBL] [Abstract][Full Text] [Related]
26. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
[TBL] [Abstract][Full Text] [Related]
27. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
[TBL] [Abstract][Full Text] [Related]
28. Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products.
Chen SA; Chen HM; Yao YD; Hung CF; Tu CS; Liang YJ
Eur J Pharm Sci; 2012 Dec; 47(5):875-83. PubMed ID: 22985875
[TBL] [Abstract][Full Text] [Related]
29. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
Usta MF; Bivalacqua TJ; Koksal IT; Toptas B; Surmen S; Hellstrom WJ
BJU Int; 2004 Aug; 94(3):429-32. PubMed ID: 15291881
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
31. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
32. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.
Youssef S; Nguyen DT; Soulis T; Panagiotopoulos S; Jerums G; Cooper ME
Kidney Int; 1999 Mar; 55(3):907-16. PubMed ID: 10027927
[TBL] [Abstract][Full Text] [Related]
33. Effect of aminoguanidine intervention on neutrophils in diabetes inflammatory cells wound healing.
Tian M; Qing C; Niu Y; Dong J; Cao X; Song F; Ji X; Lu S
Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):635-42. PubMed ID: 24002897
[TBL] [Abstract][Full Text] [Related]
34. Renoprotective effects of a novel inhibitor of advanced glycation.
Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
Bakker SF; Tushuizen ME; Gözütok E; Çiftci A; Gelderman KA; Mulder CJ; Simsek S
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):230-5. PubMed ID: 25467215
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE-MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats.
Wu Q; Li S; Li X; Sui Y; Yang Y; Dong L; Xie B; Sun Z
J Agric Food Chem; 2015 Aug; 63(31):6989-98. PubMed ID: 26207852
[TBL] [Abstract][Full Text] [Related]
37. pH-Responsive Hydrogel With an Anti-Glycation Agent for Modulating Experimental Periodontitis.
Yu MC; Chang CY; Chao YC; Jheng YH; Yang C; Lee N; Yu SH; Yu XH; Liu DM; Chang PC
J Periodontol; 2016 Jun; 87(6):742-8. PubMed ID: 26891246
[TBL] [Abstract][Full Text] [Related]
38. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
Lassila M; Seah KK; Allen TJ; Thallas V; Thomas MC; Candido R; Burns WC; Forbes JM; Calkin AC; Cooper ME; Jandeleit-Dahm KA
J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298
[TBL] [Abstract][Full Text] [Related]
39. Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide.
Chang PC; Chien LY; Chong LY; Kuo YP; Hsiao JK
J Periodontal Res; 2013 Apr; 48(2):184-93. PubMed ID: 22924807
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cataracts in moderately diabetic rats by aminoguanidine.
Swamy-Mruthinti S; Green K; Abraham EC
Exp Eye Res; 1996 May; 62(5):505-10. PubMed ID: 8759519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
